Metastatic Castration-resistant Prostate Cancer: Piling Up the Benefits of Chemotherapy
- PMID: 24908474
- DOI: 10.1016/j.eururo.2014.05.030
Metastatic Castration-resistant Prostate Cancer: Piling Up the Benefits of Chemotherapy
Comment on
-
Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies.Eur Urol. 2015 Aug;68(2):228-35. doi: 10.1016/j.eururo.2014.04.015. Epub 2014 May 2. Eur Urol. 2015. PMID: 24837187
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
